Works matching DE "FIDAXOMICIN"

Results: 122

Novel fidaxomicin antibiotics through site-selective catalysis.

Published in:

Communications Chemistry, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42004-021-00501-6

By:

Dailler, David;
Dorst, Andrea;
Schäfle, Daniel;
Sander, Peter;
Gademann, Karl

Publication type:

Article

Fecal microbiota transplantation in treating Clostridium difficile infection.

Published in:

Journal of Digestive Diseases, 2014, v. 15, n. 8, p. 405, doi. 10.1111/1751-2980.12160

By:

Brown, William R

Publication type:

Article

Whole-Genome Sequencing Demonstrates That Fidaxomicin Is Superior to Vancomycin for Preventing Reinfection and Relapse of Infection With Clostridium difficile.

Published in:

Journal of Infectious Diseases, 2014, v. 209, n. 9, p. 1446, doi. 10.1093/infdis/jit598

By:

Eyre, David W.;
Babakhani, Farah;
Griffiths, David;
Seddon, Jaime;
Del Ojo Elias, Carlos;
Gorbach, Sherwood L.;
Peto, Tim E. A.;
Crook, Derrick W.;
Walker, A. Sarah

Publication type:

Article

Hit evaluation of an α-helical peptide: Ala-scan, truncation and sidechain-to-sidechain macrocyclization of an RNA polymerase Inhibitor.

Published in:

Biological Chemistry, 2019, v. 400, n. 3, p. 333, doi. 10.1515/hsz-2018-0333

By:

Kamal, Ahmed Ashraf Moustafa;
Habib, Monica;
Haupenthal, Joerg;
Hartmann, Rolf Wolfgang;
Empting, Martin

Publication type:

Article

Fidaxomicin: A New Addition to the Clostridium difficile Armamentarium.

Published in:

Current Medical Literature: Gastroenterology, 2012, v. 31, n. 4, p. 95

By:

Bookstaver, P. Brandon;
James, Teldrin D.;
Siddiqui, Wajid;
Bland, Christopher M.;
Ahmed, Yasir;
Koch, Marla D.;
Quidley, April Miller

Publication type:

Article

Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes.

Published in:

Infection, 2021, v. 49, n. 3, p. 475, doi. 10.1007/s15010-020-01567-5

By:

Escudero-Sánchez, Rosa;
Valencia-Alijo, Angela;
Cuéllar Tovar, Sandra;
Merino-de Lucas, Esperanza;
García Fernández, Sergio;
Gutiérrez-Rojas, Ángela;
Ramos-Martínez, Antonio;
Salavert Lletí, Miguel;
Castro Hernández, Iván;
Giner, Livia;
Cobo, Javier

Publication type:

Article

Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.

Published in:

Infection, 2017, v. 45, n. 4, p. 425, doi. 10.1007/s15010-017-0981-8

By:

Pichenot, Marie;
Héquette-Ruz, Rozenn;
Guern, Remi;
Grandbastien, Bruno;
Charlet, Clément;
Wallet, Frédéric;
Schiettecatte, Sophie;
Loeuillet, Fanny;
Guery, Benoit;
Galperine, Tatiana

Publication type:

Article

A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany.

Published in:

Infection, 2016, v. 44, n. 5, p. 599, doi. 10.1007/s15010-016-0894-y

By:

Watt, Maureen;
McCrea, Charles;
Johal, Sukhvinder;
Posnett, John;
Nazir, Jameel

Publication type:

Article

Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin.

Published in:

2017

By:

Konturek, Peter C.;
Haziri, Drilon;
Helfritzsch, Harry;
Hess, Thomas;
Harsch, Igor a.

Publication type:

journal article

Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-64882-9

By:

Abutaleb, Nader S.;
Seleem, Mohamed N.

Publication type:

Article

Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin.

Published in:

2018

By:

Kuehne, Sarah A;
Dempster, Andrew W;
Collery, Mark M;
Joshi, Nimitray;
Jowett, Jamie;
Kelly, Michelle L;
Cave, Rory;
Longshaw, Chris M;
Minton, Nigel P

Publication type:

journal article

Treatment of Clostridium difficile infection in a French university hospital.

Published in:

Scandinavian Journal of Gastroenterology, 2015, v. 50, n. 10, p. 1253, doi. 10.3109/00365521.2015.1033746

By:

Khanafer, Nagham;
Blais, Lucie;
Barbut, Frédéric;
Hirschel, Bernard;
Vanhems, Philippe

Publication type:

Article

Emerging therapies for Clostridium difficile infection -- focus on fidaxomicin.

Published in:

Infection & Drug Resistance, 2013, v. 6, p. 41, doi. 10.2147/IDR.S24434

By:

Chaparro-Rojas, Fredy;
Mullane, Kathleen M.

Publication type:

Article

Clostridioides Difficile: A Concise Review of Best Practices and Updates.

Published in:

Journal of Primary Care & Community Health, 2024, p. 1, doi. 10.1177/21501319241249645

By:

Yakout, Abdelrahman;
Bi, Yan;
Harris, Dana M.

Publication type:

Article

Fidaxomicin (Dificid) for Clostridium difficile Infection.

Published in:

American Family Physician, 2013, v. 87, n. 3, p. 211

By:

PATEL, DHIREN;
GOLDMAN-LEVINE, JENNIFER D.

Publication type:

Article

Cost-effectiveness analysis of initial treatment strategies for mild-to-moderate Clostridium difficile infection in hospitalized patients.

Published in:

American Journal of Health-System Pharmacy, 2018, v. 75, n. 15, p. 1110, doi. 10.2146/ajhp170554

By:

Ford, Diana C.;
Schroeder, Mary C.;
Ince, Dilek;
Ernst, Erika J.

Publication type:

Article

Probable fidaxomicin-induced pancytopenia.

Published in:

American Journal of Health-System Pharmacy, 2018, v. 75, n. 8, p. 532, doi. 10.2146/ajhp170239

By:

Axtell, Samantha;
student, Aisha Shokoya Pharm.D.;
Yocum, Christine

Publication type:

Article

Fidaxomicin.

Published in:: Australian Prescriber, 2013, v. 36, n. 4, p. 140
Publication type:: Article

How Safe Are Recently FDA-Approved Antimicrobials? A Review of the FDA Adverse Event Reporting System Database.

Published in:

Pharmacotherapy, 2014, v. 34, n. 12, p. 1324, doi. 10.1002/phar.1519

By:

Khadem, Tina M.;
Manen, Robbert P.;
Brown, Jack

Publication type:

Article

The Use of Fidaxomicin for Treatment of Relapsed Clostridium difficile Infections in Patients with Cancer.

Published in:

Pharmacotherapy, 2014, v. 34, n. 11, p. 1220, doi. 10.1002/phar.1479

By:

Esmaily‐Fard, Amin;
Tverdek, Frank P.;
Crowther, David M.;
Ghantoji, Shashank S.;
Adachi, Javier A.;
Chemaly, Roy F.

Publication type:

Article

An Antimicrobial Stewardship Program's Real-World Experience with Fidaxomicin for Treatment of Clostridium difficile Infection: A Case Series.

Published in:

Pharmacotherapy, 2014, v. 34, n. 9, p. 901, doi. 10.1002/phar.1451

By:

Vargo, Craig A.;
Bauer, Karri A.;
Mangino, Julie E.;
Johnston, Jessica E.W.;
Goff, Debra A.

Publication type:

Article

Recommendations for the management of Clostridioides difficile infection in adults and comparison with updated ACG, ESCMID and IDSA/SHEA guidelines.

Published in:

Family Medicine & Primary Care Review, 2024, v. 26, n. 3, p. 352, doi. 10.5114/fmpcr.2024.142011

By:

BARAN, MATEUSZ PIOTR;
DROBNIK, JAROSŁAW;
BELOVIČOVÁ, MÁRIA;
MORICOVÁ, ŠTEFÁNIA;
POBROTYN, PIOTR

Publication type:

Article

Fidaxomicin: A Review of Its Use in Patients with Clostridium difficile Infection.

Published in:

2013

By:

Scott, Lesley

Publication type:

Journal Article

Clostridium difficile infection in patients after solid organ transplantations.

Published in:

Advances in Hygiene & Experimental Medicine / Postepy Higieny i Medycyny Doswiadczalnej, 2020, v. 74, p. 198, doi. 10.5604/01.3001.0014.2022

By:

Dudzicz, Sylwia;
Adamczak, Marcin;
Więcek, Andrzej

Publication type:

Article

Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.

Published in:

PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170258

By:

Baro, Emilie;
Galperine, Tatiana;
Denies, Fanette;
Lannoy, Damien;
Lenne, Xavier;
Odou, Pascal;
Guery, Benoit;
Dervaux, Benoit

Publication type:

Article

Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production.

Published in:

PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161200

By:

Chilton, Caroline H.;
Crowther, Grace S.;
Ashwin, Helen;
Longshaw, Chris M.;
Wilcox, Mark H.

Publication type:

Article

A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile–associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation.

Published in:

Clinical Infectious Diseases, 2019, v. 68, n. 2, p. 196, doi. 10.1093/cid/ciy484

By:

Mullane, Kathleen M;
Winston, Drew J;
Nooka, Ajay;
Morris, Michele I;
Stiff, Patrick;
Dugan, Michael J;
Holland, Henry;
Gregg, Kevin;
Adachi, Javier A;
Pergam, Steven A;
Alexander, Barbara D;
Dubberke, Erik R;
Broyde, Natalya;
Gorbach, Sherwood L;
Sears, Pamela S

Publication type:

Article

Reply to Fabre et al.

Published in:

Clinical Infectious Diseases, 2018, v. 67, n. 12, p. 1958, doi. 10.1093/cid/ciy475

By:

McDonald, L Clifford;
Johnson, Stuart;
Bakken, Johan S;
Garey, Kevin W;
Kelly, Ciaran;
Gerding, Dale N

Publication type:

Article

Building a Better Crystal Ball for Predicting Complications of Clostridium difficile Infection.

Published in:

2015

By:

Aronoff, David M.

Publication type:

Editorial

Risk Estimation for Recurrent Clostridium difficile Infection Based on Clinical Factors.

Published in:

Clinical Infectious Diseases, 2014, v. 58, n. 10, p. 1386, doi. 10.1093/cid/ciu107

By:

D'Agostino, Ralph B.;
Collins, Sylva H.;
Pencina, Karol M.;
Kean, Yin;
Gorbach, Sherwood

Publication type:

Article

Hypersensitivity Reactions Associated With Fidaxomicin Use.

Published in:

Clinical Infectious Diseases, 2014, v. 58, n. 4, p. 537, doi. 10.1093/cid/cit719

By:

Iarikov, Dmitri E.;
Alexander, John;
Nambiar, Sumathi

Publication type:

Article

An Economic Analysis: Is Fidaxomicin Worth the Cost?

Published in:

2014

By:

Shah, Hemal;
Doyle, Joseph J.;
Belletti, Daniel A.

Publication type:

Letter to the Editor

Is Fidaxomicin Worth the Cost? The Verdict Is Still Out!

Published in:

2014

By:

Hartzema, Abraham G.;
Chen, Chao

Publication type:

Letter to the Editor

Reply to Simon, Shah et al, and Hartzema and Chen.

Published in:

2014

By:

Bartsch, Sarah M.;
Umscheid, Craig A.;
Fishman, Neil;
Lee, Bruce Y.

Publication type:

Letter to the Editor

Cost-Effectiveness of Fidaxomicin for Clostridium difficile Treatment.

Published in:

2014

By:

Simon, Matthew S.

Publication type:

Letter to the Editor

Is Fidaxomicin Worth the Cost? An Economic Analysis.

Published in:

Clinical Infectious Diseases, 2013, v. 57, n. 4, p. 555, doi. 10.1093/cid/cit346

By:

Bartsch, Sarah M.;
Umscheid, Craig A.;
Fishman, Neil;
Lee, Bruce Y.

Publication type:

Article

Fidaxomicin “Chaser” Regimen Following Vancomycin for Patients With Multiple Clostridium difficile Recurrences.

Published in:

2013

By:

Johnson, Stuart;
Gerding, Dale N.

Publication type:

Letter

Enantioselective Synthesis of Putative Lipiarmycin Aglycon Related to Fidaxomicin/Tiacumicin B.

Published in:

Angewandte Chemie International Edition, 2015, v. 54, n. 6, p. 1929, doi. 10.1002/anie.201409475

By:

Erb, William;
Grassot, Jean-Marie;
Linder, David;
Neuville, Luc;
Zhu, Jieping

Publication type:

Article

Total Synthesis of the Tiacumicin B (Lipiarmycin A3/Fidaxomicin) Aglycone.

Published in:

Angewandte Chemie International Edition, 2015, v. 54, n. 6, p. 1937, doi. 10.1002/anie.201409510

By:

Glaus, Florian;
Altmann, Karl-Heinz

Publication type:

Article

Total Synthesis of the Protected Aglycon of Fidaxomicin (Tiacumicin B, Lipiarmycin A3).

Published in:

Angewandte Chemie International Edition, 2015, v. 54, n. 6, p. 1933, doi. 10.1002/anie.201409464

By:

Miyatake-Ondozabal, Hideki;
Kaufmann, Elias;
Gademann, Karl

Publication type:

Article

Prescribing Trends for Oral Vancomycin and Fidaxomicin after Guideline and Formulary Changes in Ontario, Canada: An Interrupted Time-Series Analysis.

Published in:

Canadian Journal of Hospital Pharmacy / Journal Canadien de la Pharmacie Hospitalière, 2024, v. 77, n. 3, p. 1, doi. 10.4212/cjhp.3560

By:

Maximos, Mira;
Maxwell, Colleen;
Gamble, John-Michael

Publication type:

Article

Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy.

Published in:

BMC Infectious Diseases, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2334-13-148

By:

Miller, Mark A.;
Louie, Thomas;
Mullane, Kathleen;
Weiss, Karl;
Lentnek, Arnold;
Golan, Yoav;
Kean, Yin;
Sears, Pam

Publication type:

Article

Fidaxomicin - the new drug for Clostridium difficile infection.

Published in:

Indian Journal of Medical Research, 2015, v. 141, n. 4, p. 398, doi. 10.4103/0971-5916.159251

By:

Vaishnavi, Chetana

Publication type:

Article

Australasian Society of Infectious Diseases updated guidelines for the management of Clostridioides difficile infection in adults and children in Australia and New Zealand.

Published in:

Internal Medicine Journal, 2025, v. 55, n. 3, p. 503, doi. 10.1111/imj.16638

By:

Longhitano, Anthony;
Roder, Christine;
Blackmore, Tim;
Campbell, Anita;
May, Meryta;
Athan, Eugene

Publication type:

Article

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses.

Published in:

European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 6, p. 1187, doi. 10.1007/s10096-019-03525-y

By:

Vehreschild, Maria J. G. T.;
Cornely, Oliver A.;
Adomakoh, Nicholas;
Kazeem, Gbenga;
Georgopali, Areti;
Karas, Andreas;
Guery, Benoit

Publication type:

Article

Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain.

Published in:

European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 6, p. 1105, doi. 10.1007/s10096-019-03503-4

By:

Rubio-Terrés, Carlos;
Rubio-Rodríguez, Darío;
Aguado, José María;
Almirante, Benito;
Cobo, Javier;
Grau, Santiago;
Salavert, Miguel;
González Antona Sánchez, Elena;
López Gutiérrez, Cristina

Publication type:

Article

Management of adult Clostridium difficile digestive contaminations: a literature review.

Published in:

European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 2, p. 209, doi. 10.1007/s10096-018-3419-z

By:

Mathias, Fanny;
Curti, Christophe;
Montana, Marc;
Bornet, Charléric;
Vanelle, Patrice

Publication type:

Article

Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE).

Published in:

2019

By:

Vehreschild, Maria J. G. T.;
Taori, Surabhi;
Goldenberg, Simon D.;
Thalhammer, Florian;
Bouza, Emilio;
van Oene, Joop;
Wetherill, Graham;
Georgopali, Areti

Publication type:

Correction Notice

Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE).

Published in:

European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 11, p. 2097, doi. 10.1007/s10096-018-3344-1

By:

Vehreschild, Maria J. G. T.;
Taori, Surabhi;
Goldenberg, Simon D.;
Thalhammer, Florian;
Bouza, Emilio;
van Oene, Joop;
Wetherill, Graham;
Georgopali, Areti

Publication type:

Article

The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohort.

Published in:

European Journal of Clinical Microbiology & Infectious Diseases, 2017, v. 36, n. 2, p. 295, doi. 10.1007/s10096-016-2802-x

By:

Fehér, C.;
Múñez Rubio, E.;
Merino Amador, P.;
Delgado-Iribarren Garcia-Campero, A.;
Salavert, M.;
Merino, E.;
Maseda Garrido, E.;
Díaz-Brito, V.;
Álvarez, M.;
Mensa, J.

Publication type:

Article